MedPath

Factors controlling calciprotein particle (CPP) formation in peritoneal dialysis (PD) fluid

Not Applicable
Completed
Conditions
End stage kidney disease
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12613000749707
Lead Sponsor
Eastern Health Integrated Renal Service
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
15
Inclusion Criteria

Peritoneal dialysis patients
A peritoneal equilibration test (PET) within the last 6 months

Exclusion Criteria

Unable to comply with the protocol
Allergy or problem with one of the PD fluid solutions proposed
Peritonitis within the last 6 weeks

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CPP levels will be estimated by assessing the apparent reduction in total fetuin-A concentration (measured by specific ELISA) after high-speed centrifugation as previously described in Smith ER et al 2013 Nephrology 18(3):215-21.[Once a week after each exchange for 8 weeks]
Secondary Outcome Measures
NameTimeMethod
Fluid pH will be measured by potentiometry using a pH electrode. [Once a week after each exchange for 8 weeks]
© Copyright 2025. All Rights Reserved by MedPath